Here's what's in our FemTech market report
In our femtech market deck, you will find everything you need to understand the market
SUMMARY
Here's what's in our FemTech market report: a 2026, 210+ page global market deck covering market size, competitors, funding, business models, growth drivers, startup risks and the technologies reshaping women's health.
The report uses a deliberately tighter definition of FemTech than many market studies. Generic fitness, broad wellness and general healthcare software stay outside the core scope unless the product is genuinely built around female biology, a women's health condition or a specific care journey.
One of the clearest shifts in the market is how far FemTech has moved beyond period and fertility apps. Menopause care, pelvic health, maternal care, diagnostics, devices and clinically integrated products now matter just as much to understanding where the market is going.
The market-size number is only useful if the definition behind it is clear. FemTech estimates can vary wildly online, so the report builds its sizing from underlying categories, shows the assumptions and then cross-checks the result against outside data.
The business-model section focuses on a hard truth in women's health: solving a real problem does not automatically create good economics. In many categories, the real question is who pays: the patient, an employer, an insurer, a clinic or a healthcare system.
That also changes how growth should be read. More awareness helps, but the stronger upside comes from clinical validation, reimbursement, employer support and better integration with providers, because those factors can turn demand into actual adoption and revenue.
Competition is fragmented in a useful way. A menopause clinic, a fertility app, a pelvic-health device and an employer-sponsored care platform can all sit inside FemTech while competing for completely different users, buyers and budgets.
The funding section therefore looks past round counts. It asks whether investors are rewarding stronger retention, clearer reimbursement paths, clinical integration, devices, diagnostics and distribution models that have a believable route to revenue.
The report is also pretty clear about why FemTech startups fail. Weak willingness to pay, poor retention, limited evidence, reimbursement friction, trust problems and underestimated sales complexity can sink a company even when the health need itself is obvious.
This is best suited to founders, investors, operators and strategy teams who want a practical global view, not a huge country-by-country statistical database. The report is delivered digitally in English and currently starts at $49 as a one-time purchase.
Is this FemTech market report actually up to date?
The current New Market Pitch FemTech Market Report is the 2026 edition, built around the companies, funding activity, technologies and market shifts shaping FemTech now.
FemTech changes quickly, especially outside the older period-tracking and fertility categories. The report covers areas such as menopause, pelvic health, maternal care, diagnostics, devices and clinically integrated care, so buyers get a view of where the market is moving today rather than an old snapshot of what FemTech used to look like.
What do I actually get in the FemTech market report?
The FemTech Market Report gives you 210+ pages of research across 12 sections, from market size and competitors to funding, business models, growth drivers and startup risks.
We built the report for people who want to understand whether the FemTech opportunity is attractive, where the strongest opportunities sit and what can make a company work or fail. It goes well beyond a market-size chart or a directory of startups.
| Section | What you get |
|---|---|
| Market Definition | A clear view of what belongs in FemTech |
| Market Opportunity | Where the strongest opportunities appear to be |
| Market Size | Current sizing and forward potential |
| Pain Points | What patients, clinicians, employers and insurers actually need |
| Tech & Infrastructure | Devices, diagnostics, care models and enabling technology |
| Value Creation | Where FemTech companies can make money |
| Market Challenges | The biggest barriers holding companies back |
| Growth Drivers | What could push the market further |
| Investor Bets | Where investors are placing their bets |
| Top Players | Leading companies and startup clusters |
| Startup Killers | Common reasons FemTech startups struggle |
| Startup Strategies | What stronger companies are doing differently |
This market map, featured in our femtech market deck, highlights top companies and startups in the femtech market
What exactly does this report count as FemTech?
Our FemTech report uses a clear market definition covering technology-enabled products and services built around women's reproductive health and other female-specific health needs.
That includes menstrual and cycle health, fertility, contraception, pregnancy, postpartum care, menopause, pelvic health, sexual health and technologies addressing conditions such as breast and gynecological cancers.
We keep broad fitness, generic wellness and general healthcare products outside the market unless the product is genuinely built around female biology, a women's health condition or a specific care journey. That tighter definition makes the market-size work much more useful, too.
| Included in the FemTech market | Outside the core scope |
|---|---|
| Menstrual and cycle health | General fitness products |
| Fertility and contraception | Broad wellness apps |
| Pregnancy and postpartum | General healthcare software |
| Menopause | Products simply marketed toward women |
| Pelvic and sexual health | Products with no female-specific care focus |
| Female-specific clinical conditions | Broad mental-health products |
If you want more recent data on this point, please see our latest femtech market report.
Does the FemTech report include a market size and forecast I can actually use?
The FemTech Market Report includes our own market-size work and a forward-looking view of how large the market could become.
FemTech estimates found online can be wildly different because researchers often define the market differently. We start by deciding exactly what belongs inside FemTech, build the estimate from the underlying categories and then cross-check the result against outside market data.
The report also shows the assumptions behind the sizing. That makes it easier to judge whether the number makes sense for your own investment, strategy or business plan instead of simply copying a headline figure.
As this chart shows, and as featured in our femtech market deck, search interest in femtech has increased significantly
Is this a global FemTech report, or mostly focused on one country?
The FemTech Market Report takes a global view of the industry rather than focusing the analysis on one national market.
We look across the companies, technologies, funding activity and business models shaping FemTech internationally. The report works well for someone trying to understand the overall market and the main competitive clusters.
It is less suited to someone who specifically needs a large country-by-country spreadsheet with detailed local statistics for dozens of markets. That level of geographic granularity is outside the main purpose of the deck.
Does the FemTech report include startups, or just the big companies?
The FemTech Market Report includes emerging startups alongside more established names, so you can see where new competition is coming from as well as who already has scale.
The company analysis reaches across menopause, fertility, hormonal health, pelvic health, maternal care, diagnostics and other parts of women's health. Companies such as Flo, Clue, Maven Clinic and Natural Cycles appear when they help explain a wider competitive or strategic pattern.
We use company examples to understand the market rather than filling pages with a long startup directory.
This chart, included in our femtech market deck, shows annual VC investment in femtech startups
Does the FemTech report cover recent funding and what investors are backing?
The FemTech Market Report includes funding activity and an Investor Bets section showing which kinds of women's health companies are attracting investor attention.
We look at what the funding actually suggests rather than simply counting rounds. That includes whether investors appear to favor stronger retention, clinical integration, reimbursement potential, employer distribution, devices, diagnostics or other models with clearer paths to revenue.
Funding databases are part of the research inputs, although the report is designed for market analysis rather than as a complete database of every FemTech round ever announced.
If you want more recent data on this point, please see our latest femtech market report.
Will the FemTech report show me who the main competitors are?
The FemTech Market Report maps the leading companies and competitive clusters across the main parts of the industry.
That distinction between clusters is useful because a menopause clinic, a fertility app, a pelvic-health device and an employer-sponsored women's health platform can all sit inside FemTech while selling completely different products to different buyers.
The competitive analysis helps you see where markets are getting crowded, where strong names have already emerged and where there may still be room for new companies.
This chart, included in our femtech market deck, shows how Flo Health is capturing share in femtech
Does the FemTech report explain how companies actually make money?
The FemTech Market Report compares the main ways women's health companies turn demand into revenue, including consumer payments, employers, insurers, clinics, diagnostics, devices and software.
This section gets into a problem that is easy to miss in FemTech: a product can solve a real health problem and still have weak economics. Patients may love the product but pay very little. Employers may pay instead. Some businesses need reimbursement. Others depend on clinicians, hospitals or recurring consumer purchases.
We look at who uses the product, who pays for it and how difficult that revenue is to capture.
If you want more recent data on this point, please see our latest femtech market report.
Does the FemTech report go beyond period and fertility apps?
The FemTech Market Report covers devices, diagnostics, care platforms, monitoring tools and healthcare infrastructure alongside consumer apps.
The modern FemTech market has moved much further than period tracking. We look at areas including menopause care, maternal health, pelvic health, hormonal conditions, diagnostics and clinically integrated products.
That broader coverage makes the report more useful for buyers looking for newer opportunities rather than another overview dominated by cycle-tracking apps.
This chart, included in our femtech market deck, shows annual funding in femtech startups
Does the FemTech report cover regulation, reimbursement and clinical evidence?
The FemTech Market Report covers regulation, reimbursement, clinical evidence, privacy and other healthcare barriers that can decide whether a product actually gets adopted.
These issues become especially important as FemTech companies move closer to diagnostics, devices and clinical care. Medical claims can raise the evidence burden. Reimbursement can determine whether the economics work. Clinician adoption can make distribution much easier or much harder.
The report also looks at privacy and trust, which become particularly sensitive when companies handle reproductive, sexual or hormonal health data.
Does the report explain what could actually make FemTech grow faster?
The FemTech Market Report breaks down the factors that could push women's health technology further instead of relying on a generic industry growth rate.
We look at factors such as stronger awareness of women's health needs, better products, more clinical validation, improved reimbursement, employer support and better integration with healthcare providers.
Some of those drivers are already visible. Others still depend on changes that have not fully happened yet. We make that distinction clear so readers can see which parts of the growth story look strong and which still rely on assumptions.
This chart, included in our femtech market deck, compares the main business model options for menopause telehealth platforms
Does the FemTech report show why startups in this market fail?
The FemTech Market Report has a dedicated Startup Killers section covering the recurring reasons women's health startups run into trouble.
Common problems include weak willingness to pay, poor retention after the initial health need passes, limited clinical evidence and go-to-market plans that underestimate how hard it is to sell through employers, insurers or clinicians.
We also look at reimbursement friction, fragmented care journeys and trust problems. A very real health problem can still sit underneath a bad business.
If you want more recent data on this point, please see our latest femtech market report.
Does the report show what successful FemTech companies are doing differently?
The FemTech Market Report studies the strategies stronger women's health companies use to build trust, retention, distribution and a more durable position.
We look at examples from companies such as Flo, Clue, Maven Clinic and Natural Cycles to see how successful players have built recurring usage, expanded across care journeys, improved clinical credibility or found stronger distribution.
For someone building or investing in a FemTech company, this section helps turn competitor research into something more practical than a list of logos.
This chart, featured in our femtech market deck, illustrates how revenue is divided among customer segments in the femtech market
How did you calculate the FemTech market size and build the report?
We built the FemTech Market Report using first-principles market sizing, company research, funding data, public datasets, industry research and cross-checks against outside estimates.
The market-size process starts with the definition of FemTech itself. From there, we estimate the underlying categories and compare the result with published external numbers.
We also show the assumptions behind the analysis. If two sources disagree sharply on the size of FemTech, readers can understand where those differences come from instead of wondering which number to trust.
Can I see where the FemTech data comes from?
The FemTech Market Report identifies the sources behind key figures and explains the assumptions used for the main analysis.
Our research draws from company information, funding databases, public datasets, expert input and industry research. We use several types of sources because no single dataset gives a complete picture of FemTech.
Source transparency is especially useful for market sizing, where changing the definition of FemTech can move the final estimate dramatically.
This chart, included in our femtech market deck, shows how cycle tracking app technology has evolved over time
How long is the FemTech report, and what format do I get?
The FemTech Market Report is a digital English-language deck of 210+ pages, organized so you can scan the research much faster than a traditional long-form industry report.
The report uses charts, market maps, company examples and concise analysis across 12 sections. You can read it from beginning to end or jump directly to areas such as market size, competitors, investors, startup risks or technology.
The digital deck format also makes it easier to come back to individual sections when you are working on an investment memo, business plan, strategy project or market review.
Who is the FemTech Market Report actually useful for?
The FemTech Market Report is mainly built for founders, investors, operators and strategists who need to make a real decision about the women's health market.
Founders can use it to test the size of an opportunity, understand competitors, see how companies make money and spot common failure patterns. Investors can use it to compare market segments, funding activity, leading players and growth drivers.
It can also help strategy teams or operators who need a fast way to understand where FemTech is moving without spending days assembling the market from dozens of separate sources.
If you want more recent data on this point, please see our latest femtech market report.
In our femtech market deck, we identify pain points entrepreneurs should prioritize
How much does the FemTech Market Report cost?
The New Market Pitch FemTech Market Report currently starts at $49 as a one-time purchase, with PRO, PRO+ and PRO++ options.
There is no recurring subscription attached to the report purchase. The current product page lists PRO at $49, PRO+ at $79 and PRO++ at $99.
New Market Pitch also advertises multi-report discounts for buyers purchasing several market reports at once.
| Option | Current price | Payment |
|---|---|---|
| PRO | $49 | One-time |
| PRO+ | $79 | One-time |
| PRO++ | $99 | One-time |
Where can I buy the latest FemTech market report?
You can buy the latest New Market Pitch FemTech Market Report directly from NewMarketPitch.com, with the report delivered digitally in English.
The current product is the 2026 FemTech Market Report and is available as a one-time purchase.
If you are looking for a recent FemTech market research report, a FemTech industry report in English or current FemTech market data, the latest version is available directly from New Market Pitch.
This chart, included in our femtech market deck, illustrates how revenue is divided by region across Europe, Asia, North America, Africa, and South America in the femtech market
